In the first quarter of 2024, 7 new stem cell drugs IND were added in China, covering stroke, diabetic foot, COPD and so on.

depth! Report on the Development trend of Cell and Gene Therapy

A major breakthrough in stem cell treatment of diabetes: Deng Hongkui / Li Cheng of Peking University worked together to find that ceramide metabolic remodeling promotes the functional maturation of human pluripotent stem cell-derived islet cells.

Five CGT therapies are available worldwide, with the most expensive price of $4.25 million (January-April)

Guangdong Provincial Health Commission took the lead in establishing China's first stem cell clinical research quality control center.